Policy & Regulation
Stay informed about the latest cannabis regulation developments and changes with Business of Cannabis. Learn about new laws, policies and more.
Policy & Regulation · page 3
- UK & Europe
New Report: Germany’s Cannabis Market Crosses €1.15bn as Reimbursement Era Ends
Germany’s medical cannabis market reached approximately €1.15bn in 2026, with private self-pay prescriptions now generating around 75% of total market value, according to a new whitepaper published today by Business of Cannabis and Prohibition Partners.
- Adult-Use
Thailand Presses Medical-Only Cannabis Bill Toward Cabinet as Enforcement Drive Widens
Thailand’s Ministry of Public Health is pressing ahead with a draft Cannabis and Hemp Act that would restrict its liberal cannabis market to purely medical and research use cases.
- Hemp Industry
US Hemp Industry Wins a Stay of Execution as Senate Delays Ban Until December
The US hemp industry has successfully bought itself some additional time to find a permanent solution to the incoming federal ban.
- UK & Europe
Spain’s Tobacco Crackdown Could Quietly Wipe Out Its Cannabis Clubs
Last week, Spain’s government approved a draft tobacco law that never once mentions cannabis, yet could dismantle the everyday activity of the country’s thriving cannabis social clubs.
- Patient Access
‘Everything in Our Power’: German Patient Groups Fight to Overturn Cannabis Insurance Cuts
Earlier this month (July 10, 2026), the German government voted through a sweeping set of provisions set to significantly impact medical cannabis patients who have their prescriptions covered by their statutory health insurance.
- Opinion
Opinion: New Labour Administration Can End Britain’s Failed Cannabis Experiment
Written by Omar Khan, Chief Communications and Public Affairs Officer, High Tide Inc.
- Hemp Industry
Bipartisan Bill Seeks to Overturn Intoxicating Hemp Ban and Regulate Multi-Billion Dollar Sector
The US intoxicating hemp market, thought to be worth around $28bn in annual sales, could yet be saved from a devastating ban set to be implemented in a matter of months.
- Opinion
Patients First: What Training the Police Taught Me About Medical Cannabis
As new national guidance instructs officers to treat medical cannabis users as patients first, James Duckenfield, CEO of Glass Pharms, reflects on what training police forces has taught him about the gap between the law and the general understanding of the legal landscape, and how the industry as a whole can help close it.
- US & Canada
DEA Rescheduling Hearing Closes as States’ Own Witness Concedes Regulation Reduces Crime
The Drug Enforcement Administration’s (DEA) administrative hearing on cannabis rescheduling saw both sides make their closing arguments on Wednesday, July 15, bringing the 17-day proceedings to a broadly positive close.
- US & Canada
US Rescheduling Hearing Nears End as Opposition’s Own Witness Acknowledges Cannabis Fits Schedule III Standard
Tomorrow (July 15, 2026) the landmark administrative hearing on US cannabis rescheduling will come to a close.
- Patient Access
Germany Bans Cannabis Flowers from GKV and Mandates Six-Month Trial for Extracts
Germany has today voted to ban medical cannabis flower from its statutory health insurance scheme, in a controversial move critics say will have an outsized impact on the ‘seriously ill’.
- Clinical Research
Why Medical Companies Win Rescheduling, Whatever Happens to Adult-Use
This week, what is perhaps the most consequential hearing in the history of the US, and indeed the global cannabis industry, is taking place in Arlington, Virginia.
